Clinical Trial Update: GSK2239633 FTIH Study [Phase 1]

View source ↗

Summary

This update reports completion of GlaxoSmithKline's Phase 1 trial of GSK2239633 FTIH in asthma.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Asthma

Drugs mentioned

• GSK2239633 FTIH (GSK2239633)

Snippet

Sponsor: GlaxoSmithKline | Conditions: Asthma | Phase 1 | Status: COMPLETED